Sympathetic signatures of cardiovascular disease: a blueprint for development of targeted sympathetic ablation therapies

Hypertension. 2012 Mar;59(3):545-7. doi: 10.1161/HYPERTENSIONAHA.111.182899. Epub 2012 Feb 6.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / administration & dosage*
  • Animals
  • Heart / innervation*
  • Heart Failure / drug therapy*
  • Kidney / innervation*
  • Losartan / administration & dosage*
  • Sympathetic Nervous System / physiopathology*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Losartan